Physician profile
Fiona Simpkins
NPI 1710916077
$11,365.08
in general payments reported to CMS, 2019-2025
6 companies · $71.18 in 2025
The $71.18 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $1,110 · 2023: $8,064 · 2024: $1,966 · 2025: $71.18.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,150 · Grant: $809 · Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,150.00 |
| Grant | $808.83 |
| Food and Beverage | $141.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $7,200.00 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $2,060.42 | 2020-2025 | Lynparza |
| Beigene USA, INC. | $1,950.00 | 2024 | |
| Genentech USA, INC. | $102.26 | 2019 | |
| Clovis Oncology, INC. | $52.40 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fiona Simpkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.